Sepehr N. Tabrizi

14.6k total citations · 1 hit paper
299 papers, 9.8k citations indexed

About

Sepehr N. Tabrizi is a scholar working on Epidemiology, Microbiology and Surgery. According to data from OpenAlex, Sepehr N. Tabrizi has authored 299 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 200 papers in Epidemiology, 141 papers in Microbiology and 86 papers in Surgery. Recurrent topics in Sepehr N. Tabrizi's work include Cervical Cancer and HPV Research (153 papers), Reproductive tract infections research (136 papers) and Genital Health and Disease (65 papers). Sepehr N. Tabrizi is often cited by papers focused on Cervical Cancer and HPV Research (153 papers), Reproductive tract infections research (136 papers) and Genital Health and Disease (65 papers). Sepehr N. Tabrizi collaborates with scholars based in Australia, Canada and United States. Sepehr N. Tabrizi's co-authors include Suzanne M. Garland, Christopher K. Fairley, Catriona S. Bradshaw, Jane S. Hocking, Matthew P. Stevens, Andrew E. Grulich, Jørgen Skov Jensen, Dorothy A. Machalek, Richard J. Hillman and Julia Brotherton and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PEDIATRICS.

In The Last Decade

Sepehr N. Tabrizi

296 papers receiving 9.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis

2012 699 citations Dorothy A. Machalek, Fengyi Jin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sepehr N. Tabrizi Australia	52	5.7k	4.2k	3.2k	1.5k	1.1k	299	9.8k
Cathy W. Critchlow United States	57	5.7k 1.0×	2.4k 0.6×	2.1k 0.6×	1.3k 0.9×	692 0.6×	146	10.9k
Jorma Paavonen Finland	62	7.7k 1.3×	5.2k 1.2×	3.2k 1.0×	648 0.4×	817 0.7×	444	14.5k
Suzanne M. Garland Australia	65	12.5k 2.2×	5.6k 1.3×	5.9k 1.8×	1.6k 1.1×	1.5k 1.3×	569	18.9k
Catriona S. Bradshaw Australia	55	4.9k 0.9×	7.9k 1.9×	2.4k 0.8×	2.8k 1.9×	1.7k 1.6×	375	11.0k
Jørgen Skov Jensen Denmark	63	4.5k 0.8×	9.2k 2.2×	3.2k 1.0×	2.1k 1.4×	592 0.5×	278	12.2k
D Taylor‐Robinson United Kingdom	58	6.0k 1.0×	10.4k 2.5×	2.3k 0.7×	1.1k 0.7×	659 0.6×	373	13.2k
Eileen F. Dunne United States	41	6.9k 1.2×	1.2k 0.3×	3.3k 1.0×	362 0.2×	939 0.9×	112	9.8k
Henry J.C. de Vries Netherlands	51	4.1k 0.7×	3.3k 0.8×	1.7k 0.5×	1.7k 1.1×	827 0.8×	348	8.4k
Sami L. Gottlieb United States	44	5.2k 0.9×	3.5k 0.8×	1.0k 0.3×	1.4k 0.9×	1.8k 1.7×	92	9.3k
Nancy B. Kiviat United States	61	8.4k 1.5×	2.6k 0.6×	3.7k 1.2×	423 0.3×	458 0.4×	170	11.9k

Countries citing papers authored by Sepehr N. Tabrizi

Since Specialization

Citations

This map shows the geographic impact of Sepehr N. Tabrizi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sepehr N. Tabrizi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sepehr N. Tabrizi more than expected).

Fields of papers citing papers by Sepehr N. Tabrizi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sepehr N. Tabrizi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sepehr N. Tabrizi. The network helps show where Sepehr N. Tabrizi may publish in the future.

Co-authorship network of co-authors of Sepehr N. Tabrizi

This figure shows the co-authorship network connecting the top 25 collaborators of Sepehr N. Tabrizi. A scholar is included among the top collaborators of Sepehr N. Tabrizi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sepehr N. Tabrizi. Sepehr N. Tabrizi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shilling, Hannah, Gerald L. Murray, Mónica Molano, et al.. (2024). Human Papillomavirus Prevalence Among Australian Men Aged 18–35 Years in 2015–2018 According to Vaccination Status and Sexual Orientation. The Journal of Infectious Diseases. 231(2). 451–461. 4 indexed citations

Jayasinghe, Yasmin, Sepehr N. Tabrizi, Matthew P. Stevens, et al.. (2023). Pre-Vaccination Human Papillomavirus Genotypes and HPV16 Variants among Women Aged 25 Years or Less with Cervical Cancer. Pathogens. 12(3). 451–451.

Chow, Eric P. F., Christopher K. Fairley, Rebecca Wigan, et al.. (2021). Accuracy of Self-reported Human Papillomavirus Vaccination Status Among Gay and Bisexual Adolescent Males: Cross-sectional Study. JMIR Public Health and Surveillance. 7(12). e32407–e32407. 7 indexed citations

Chen, Marcus Y., Anna McNulty, Ann Avery, et al.. (2019). Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial. The Lancet Infectious Diseases. 19(8). 833–842. 44 indexed citations

Poynten, I. Mary, Tim Waterboer, Fengyi Jin, et al.. (2018). Human Papillomavirus Seroprevalence and Association with Anal HPV Infection and Squamous Intraepithelial Lesions in Australian Gay and Bisexual Men. Cancer Epidemiology Biomarkers & Prevention. 27(7). 768–775. 8 indexed citations

Smith, Kirsty, Rebecca Guy, Jennifer Danielewski, et al.. (2017). Biological and Behavioral Factors Associated With Positive Chlamydia Retests. Sexually Transmitted Diseases. 44(7). 417–422. 6 indexed citations

Machalek, Dorothy A., I. Mary Poynten, Fengyi Jin, et al.. (2016). A Composite Cytology–Histology Endpoint Allows a More Accurate Estimate of Anal High-Grade Squamous Intraepithelial Lesion Prevalence. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1134–1143. 30 indexed citations

Read, Tim, Christopher K. Fairley, Sepehr N. Tabrizi, et al.. (2016). Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium : Impact on Treatment Outcome and Resistance. Clinical Infectious Diseases. 64(3). 250–256. 54 indexed citations

Toliman, Pamela J, Steven G. Badman, James R. Allan, et al.. (2016). Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens. Journal of Clinical Microbiology. 54(7). 1734–1737. 56 indexed citations

10.

Machalek, Dorothy A., Eric P. F. Chow, Suzanne M. Garland, et al.. (2016). Human papillomavirus prevalence in unvaccinated heterosexual males following a national female vaccination program. The Journal of Infectious Diseases. 215(2). jiw530–jiw530. 32 indexed citations

11.

Subasinghe, Asvini K, et al.. (2016). Targeted Facebook Advertising is a Novel and Effective Method of Recruiting Participants into a Human Papillomavirus Vaccine Effectiveness Study. JMIR Research Protocols. 5(3). e154–e154. 29 indexed citations

12.

Roberts, Jennifer M., Fengyi Jin, Julia K. Thurloe, et al.. (2015). High reproducibility of histological diagnosis of human papillomavirus-related intraepithelial lesions of the anal canal. Pathology. 47(4). 308–313. 13 indexed citations

13.

Roberts, Jennifer M., et al.. (2015). Endocervical Adenocarcinoma In Situ Presenting in Fundal Endometrial Polyp. International Journal of Gynecological Pathology. 34(3). 228–231. 4 indexed citations

14.

Russell, Darren, et al.. (2014). Mycoplasma genitalium and its resistance to azithromycin in incarcerated men from Far North Queensland. Sexual Health. 11(6). 587–589. 3 indexed citations

15.

Fenner, Yeshe, Suzanne M. Garland, Elya E. Moore, et al.. (2012). Web-Based Recruiting for Health Research Using a Social Networking Site: An Exploratory Study. Journal of Medical Internet Research. 14(1). e20–e20. 323 indexed citations

16.

Garland, Suzanne M., Julia Brotherton, John R. Condon, et al.. (2011). Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Medicine. 9(1). 104–104. 73 indexed citations

17.

Twin, Jimmy, Elya E. Moore, Suzanne M. Garland, et al.. (2010). Chlamydia trachomatis Genotypes Among Men Who Have Sex With Men in Australia. Sexually Transmitted Diseases. 38(4). 279–285. 37 indexed citations

18.

Jensen, Jørgen Skov, Catriona S. Bradshaw, Sepehr N. Tabrizi, Christopher K. Fairley, & Ryoichi Hamasuna. (2008). Azithromycin Treatment Failure in Mycoplasma genitalium –Positive Patients with Nongonococcal Urethritis Is Associated with Induced Macrolide Resistance. Clinical Infectious Diseases. 47(12). 1546–1553. 258 indexed citations

19.

Bowden, Francis J., Barbara Paterson, Sepehr N. Tabrizi, Christopher K. Fairley, & Suzanne M. Garland. (1998). Using Self-Administered Tampons to Diagnose STDs. AIDS Patient Care and STDs. 12(1). 29–32. 5 indexed citations

20.

Faulkner-Jones, Beverly E., Sepehr N. Tabrizi, Anthony J. Borg, et al.. (1993). Detection of human papillomavirus DNA and mRNA using synthetic, type-specific oligonucleotide probes. Journal of Virological Methods. 41(3). 277–296. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact